Trial Profile
Phase I trial of KP 201 (benzhydrocodone/paracetamol) in Canada.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2023
Price :
$35
*
At a glance
- Drugs Benzhydrocodone/paracetamol (Primary)
- Indications Acute pain
- Focus Adverse reactions
- Sponsors Zevra Therapeutics
- 22 Feb 2023 According to a KemPharm media release, KemPharm has changed its name to Zevra Therapeutics.
- 12 Nov 2015 According to KemPharm Inc. media release, the company reported positive data of tamper-resistant properties of KP201/APAP.
- 25 Sep 2014 New trial record